Specifically, 3 mg of GH in 0.6 mL is approximately equivalent, on a molar basis, to 0.25 mg of AOD9604
Neurological risks appear low overall: Large population studies show no increased risk of depression, dementia, or other psychiatric conditions compared to other diabetes drugs
Review: The role of glucagon-like peptide 1 (GLP-1) in addictive disorders
Bakand S, Hayes A (2016) Toxicological considerations, toxicity assessment, and risk management of inhaled nanoparticles
In these STEP trials, most participants experienced mild to moderate symptoms, with the incidence of severe side effects being 9.8% in the semaglutide treatment group and 6.4% in the placebo group